ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

DVAX Company Profile and Key Details

NASDAQ : DVAX

Dynavax Technologies Corporation

$12.49

-0.16-1.27%

At Close 4:00 PM

61.88

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

DVAX Stock Price Chart

Stock Price Today

Dynavax Technologies Corporation (DVAX) stock declined over -1.26%, trading at $12.49 on NASDAQ, down from the previous close of $12.65. The stock opened at $12.11, fluctuating between $12.09 and $12.90 in the recent session.

Stock Snapshot

12.65

Prev. Close

12.11

Open

1.55B

Market Cap

124.07M

Number of Shares

12.09

Day Low

12.9

Day High

62.45

P/E Ratio

95.34%

Free Float in %

0.2

EPS (TTM)

4.81

Book Value

0.75

Cash Flow per Share

2.48M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 07, 2025	12.11	12.92	12.09	12.49	2.48M
Apr 04, 2025	12.74	12.87	12.49	12.65	2.34M
Apr 03, 2025	12.77	13.02	12.71	12.85	2.53M
Apr 02, 2025	12.62	13.03	12.57	12.87	1.69M
Apr 01, 2025	12.95	12.97	12.63	12.71	1.82M
Mar 31, 2025	13.43	13.46	12.92	12.97	2.98M
Mar 28, 2025	13.72	13.80	13.53	13.68	1.37M
Mar 27, 2025	13.64	13.91	13.55	13.72	1.21M
Mar 26, 2025	14.03	14.08	13.54	13.58	1.32M
Mar 25, 2025	13.77	14.01	13.74	13.98	1.54M
Mar 24, 2025	13.95	14.07	13.75	13.84	1.4M
Mar 21, 2025	13.65	13.84	13.56	13.82	3.37M
Mar 20, 2025	13.57	13.74	13.53	13.62	1.3M
Mar 19, 2025	13.90	13.99	13.59	13.64	3.03M
Mar 18, 2025	13.60	13.93	13.46	13.90	2.11M
Mar 17, 2025	13.83	13.90	13.60	13.63	1.55M
Mar 14, 2025	13.66	14.01	13.66	13.87	2.53M
Mar 13, 2025	13.78	13.91	13.64	13.69	1.06M
Mar 12, 2025	13.74	13.89	13.65	13.74	2.7M
Mar 11, 2025	14.33	14.39	13.78	13.79	3.46M

Contact Details

EmeryVille, CA 94608

United States

Website: https://www.dynavax.comContact: 510 848 5100

About Company

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Frequently Asked Questions

What is the current Dynavax Technologies Corporation (DVAX) stock price?

Dynavax Technologies Corporation (NASDAQ: DVAX) stock price is $12.49 in the last trading session. During the trading session, DVAX stock reached the peak price of $12.90 while $12.09 was the lowest point it dropped to. The percentage change in DVAX stock occurred in the recent session was -1.26% while the dollar amount for the price change in DVAX stock was -$0.16.

DVAX's industry and sector of operation?

The NASDAQ listed DVAX is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Dynavax Technologies Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of DVAX?

Ms. Meg Smith
Vice President Sales & Operations
Nicole Arndt
Senior Mang. of Investor Relations
Dr. Robert Janssen
Chief Medical Officer and Senior Vice President of Clinical Devel., Medical & Regulatory Affairs
Ms. Cecilia Vitug
Vice President of HR
Mr. Paul Cox
Vice President of Investor Relations & Corporation Communications
Ms. Kelly MacDonald
Senior Vice President & Chief Financial Officer
Mr. Ryan Spencer
Chief Executive Officer & Director
Mr. David F. Novack
Pres & Chief Operating Officer
Mr. Justin Burgess
Principal Accounting Officer & Controller
Mr. John Slebir
Senior Vice President & Gen. Counsel
Mr. Michael S. Ostrach
Advisor
Mr. Jeff P. Coon
CHRO and Senior Vice President of HR & Admin.
Mr. Donn Casale
Chief Commercial Officer

How DVAX did perform over past 52-week?

DVAX's closing price is 28.23% higher than its 52-week low of $9.74 where as its distance from 52-week high of $14.63 is -14.63%.

How many employees does DVAX have?

Number of DVAX employees currently stands at 405.

Link for DVAX official website?

Official Website of DVAX is: https://www.dynavax.com

How do I contact DVAX?

DVAX could be contacted at phone 510 848 5100 and can also be accessed through its website. DVAX operates from 2100 Powell Street, EmeryVille, CA 94608, United States.

How many shares of DVAX are traded daily?

DVAX stock volume for the day was 2.48M shares. The average number of DVAX shares traded daily for last 3 months was 2.23M.

What is the market cap of DVAX currently?

The market value of DVAX currently stands at $1.55B with its latest stock price at $12.49 and 124.07M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	405
Beta	1.23
Sales or Revenue	$232.28M
5Y Sales Change%	12.726%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic